What is the appropriate evaluation and management for a 21-year-old woman with nine months of secondary amenorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Evaluation and Management for 21-Year-Old with 9 Months of Amenorrhea

Start with a pregnancy test immediately, then obtain serum FSH, LH, estradiol, prolactin, and TSH to differentiate between functional hypothalamic amenorrhea (most likely in this age group), premature ovarian insufficiency, hyperprolactinemia, and thyroid dysfunction 1.

Initial Diagnostic Workup

Essential Laboratory Tests

Obtain the following labs on first presentation 1:

  • β-hCG (pregnancy test) - must be done first
  • Serum FSH, LH, and estradiol - pattern is more critical than absolute values
  • Prolactin level
  • TSH and free T4
  • AMH (anti-Müllerian hormone)

Add these if clinically indicated 1:

  • Total testosterone and DHEA-S if signs of hyperandrogenism (acne, hirsutism, male pattern alopecia)
  • 8 AM 17-hydroxyprogesterone if suspecting late-onset congenital adrenal hyperplasia
  • Complete blood count, comprehensive metabolic panel, liver function tests if chronic illness suspected

Critical History Elements

Focus your questioning on 1:

  • Weight changes - any loss, even if patient appears normal weight
  • Exercise patterns - hours per week, intensity, type of activity
  • Eating habits - restrictive patterns, calorie counting, food avoidance
  • Psychological stressors - college start, relationship issues, grief, anxiety
  • Medication use - particularly antipsychotics, metoclopramide, opioids
  • Galactorrhea, headaches, or visual changes - suggests prolactinoma
  • Heat/cold intolerance, fatigue - thyroid dysfunction

Physical Examination Priorities

Document 1:

  • Weight, height, BMI - compare to previous measurements if available
  • Vital signs - bradycardia suggests functional hypothalamic amenorrhea
  • Skin - look for hypercarotenemia (yellow-orange palms/soles), acanthosis nigricans, hirsutism, acne
  • Breast exam - check for galactorrhea
  • External genitalia - assess for estrogen deficiency (thin, reddened vaginal mucosa)
  • Visual field testing if prolactin elevated

Interpreting Results and Next Steps

Pattern 1: Low/Low-Normal FSH and LH with Low Estradiol

This indicates functional hypothalamic amenorrhea (FHA) - the most common cause in this age group 1.

Management approach:

  • Screen for the triad: energy deficit (undereating relative to exercise), psychological stress, and excessive exercise 1
  • Do NOT simply prescribe oral contraceptives - this masks the problem and doesn't address underlying health risks 1
  • Address energy balance first: increase caloric intake and/or reduce exercise intensity
  • Consider referral to eating disorder specialist if restrictive eating patterns present
  • Bone density assessment (DXA scan) - FHA causes significant bone loss that doesn't fully reverse even with treatment 1
  • Monitor for stress fractures, especially if athletic 1

Critical pitfall: Up to 50% of patients labeled as PCOS with oligomenorrhea and polycystic ovaries on ultrasound actually have FHA 1. Don't assume PCOS without checking gonadotropins.

Pattern 2: Elevated FSH (>25-40 IU/L) with Low Estradiol

This suggests premature ovarian insufficiency (POI) 2.

Management approach:

  • Repeat FSH in 4-6 weeks to confirm (need two elevated values)
  • Karyotype analysis - check for Turner syndrome mosaicism or fragile X premutation
  • Consider autoimmune workup if indicated
  • Hormone replacement therapy is mandatory - not optional - until age 50-51 (average age of natural menopause) 2
  • Counsel about fertility options (unpredictable ovarian function may still allow spontaneous pregnancy)

Pattern 3: Elevated Prolactin (>25 ng/mL)

Indicates hyperprolactinemia - obtain MRI pituitary 3.

Management approach:

  • If microadenoma (<1 cm): can treat with cabergoline OR oral contraceptives if not desiring pregnancy 3
  • Cabergoline is preferred over bromocriptine - more effective, better tolerated, dosed 0.25-3 mg weekly 3
  • If macroadenoma (≥1 cm): cabergoline is first-line treatment, not surgery 3
  • Recheck prolactin monthly until normalized, then MRI at 1 year 3

Pattern 4: Abnormal TSH

Treat thyroid dysfunction - both hypothyroidism and hyperthyroidism cause amenorrhea.

Pattern 5: Elevated Androgens

Consider PCOS or other hyperandrogenic disorders - obtain pelvic ultrasound, consider insulin resistance screening.

Timeline for Intervention

The Endocrine Society guideline recommends evaluation when menstrual cycle intervals persistently exceed 45 days or amenorrhea reaches 3 months 1. At 9 months, this patient is well past the threshold and requires immediate workup.

Common pitfall: Don't wait longer to evaluate. The guideline specifically states that even though many patients present after 6+ months of amenorrhea, evaluation should begin at 3 months to prevent complications like bone loss 1.

What NOT to Do

  • Don't prescribe oral contraceptives without full workup - this is the most common error and masks serious underlying conditions 1
  • Don't assume this is "just stress" without excluding organic pathology - pregnancy, prolactinoma, POI, and thyroid disease must be ruled out first 1
  • Don't tell patients with FHA to simply "gain weight" - address the underlying energy imbalance, psychological factors, and exercise patterns comprehensively 1

References

Guideline

functional hypothalamic amenorrhea: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2017

Guideline

diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.